LLY

SEC source: 0000059478-25-000022 · wk-form4_1738704180.xml · nonDerivative · entry 2

Jonsson Patrik · CIK 0001786054 · EVP&Pres, CardMetHlth, LLY USA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,480.141

SEC source: 0000059478-25-000022 · wk-form4_1738704180.xml · nonDerivative · entry 1

Jonsson Patrik · CIK 0001786054 · EVP&Pres, CardMetHlth, LLY USA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,016

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000059478-25-000024 · wk-form4_1738704227.xml · derivative · entry 3

Rau Diogo · CIK 0001860253 · EVP & CIDO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,269 shares

Expires 2025-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

SEC source: 0000059478-25-000024 · wk-form4_1738704227.xml · nonDerivative · entry 2

Rau Diogo · CIK 0001860253 · EVP & CIDO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,903.706

SEC source: 0000059478-25-000024 · wk-form4_1738704227.xml · nonDerivative · entry 1

Rau Diogo · CIK 0001860253 · EVP & CIDO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,370

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000059478-25-000026 · wk-form4_1738704275.xml · derivative · entry 7

Ricks David A · CIK 0001538604 · Director · President, Chair, and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,561 shares

Expires 2025-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

SEC source: 0000059478-25-000026 · wk-form4_1738704275.xml · nonDerivative · entry 2

Ricks David A · CIK 0001538604 · Director · President, Chair, and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 484,481.607

SEC source: 0000059478-25-000026 · wk-form4_1738704275.xml · nonDerivative · entry 1

Ricks David A · CIK 0001538604 · Director · President, Chair, and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 496,385

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000059478-25-000028 · wk-form4_1738704326.xml · derivative · entry 5

Skovronsky Daniel · CIK 0001741474 · EVP, CSO & Pres. LRL & LLY Imm

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,989 shares

Expires 2025-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

SEC source: 0000059478-25-000028 · wk-form4_1738704326.xml · nonDerivative · entry 2

Skovronsky Daniel · CIK 0001741474 · EVP, CSO & Pres. LRL & LLY Imm

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,888.36

SEC source: 0000059478-25-000028 · wk-form4_1738704326.xml · nonDerivative · entry 1

Skovronsky Daniel · CIK 0001741474 · EVP, CSO & Pres. LRL & LLY Imm

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,892

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000059478-25-000030 · wk-form4_1738704376.xml · derivative · entry 5

Van Naarden Jacob · CIK 0001661254 · EVP & Pres., Lilly Oncology

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,023 shares

Expires 2025-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

SEC source: 0000059478-25-000030 · wk-form4_1738704376.xml · nonDerivative · entry 2

Van Naarden Jacob · CIK 0001661254 · EVP & Pres., Lilly Oncology

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,458.161

SEC source: 0000059478-25-000030 · wk-form4_1738704376.xml · nonDerivative · entry 1

Van Naarden Jacob · CIK 0001661254 · EVP & Pres., Lilly Oncology

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,868

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000059478-25-000032 · wk-form4_1738704436.xml · derivative · entry 3

White Anne E. · CIK 0001752313 · EVP & Pres, Lilly Neuroscience

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,269 shares

Expires 2025-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

SEC source: 0000059478-25-000032 · wk-form4_1738704436.xml · nonDerivative · entry 2

White Anne E. · CIK 0001752313 · EVP & Pres, Lilly Neuroscience

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,380.898

SEC source: 0000059478-25-000032 · wk-form4_1738704436.xml · nonDerivative · entry 1

White Anne E. · CIK 0001752313 · EVP & Pres, Lilly Neuroscience

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,838

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000059478-25-000034 · wk-form4_1738704486.xml · derivative · entry 3

Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,269 shares

Expires 2025-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

SEC source: 0000059478-25-000034 · wk-form4_1738704486.xml · nonDerivative · entry 2

Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,636.623

SEC source: 0000059478-25-000034 · wk-form4_1738704486.xml · nonDerivative · entry 1

Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,071

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000059478-25-000008 · wk-form4_1737667237.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,705.324

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-25-000010 · wk-form4_1737667303.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,671.552

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-25-000012 · wk-form4_1737667361.xml · nonDerivative · entry 1

Hedley Mary Lynne · CIK 0001340823 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,892.323

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-25-000014 · wk-form4_1737667411.xml · nonDerivative · entry 1

LUCIANO JUAN R · CIK 0001455792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,211.283

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-25-000016 · wk-form4_1737667469.xml · nonDerivative · entry 1

Sulzberger Gabrielle · CIK 0001262388 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,539.61

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-24-000283 · wk-form4_1734470180.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,689.496

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-24-000285 · wk-form4_1734470270.xml · nonDerivative · entry 1

Hedley Mary Lynne · CIK 0001340823 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,878.965

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-24-000287 · wk-form4_1734470366.xml · nonDerivative · entry 1

JOHNSON KIMBERLY H · CIK 0001658089 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,032.146

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-24-000289 · wk-form4_1734470498.xml · nonDerivative · entry 1

LUCIANO JUAN R · CIK 0001455792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,191.301

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-24-000291 · wk-form4_1734470584.xml · nonDerivative · entry 1

Sulzberger Gabrielle · CIK 0001262388 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,532.931

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-24-000260 · wk-form4_1732137575.xml · nonDerivative · entry 2

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,586.184

SEC source: 0000059478-24-000260 · wk-form4_1732137575.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,283.654

F1 · shares: At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-24-000262 · wk-form4_1732137654.xml · nonDerivative · entry 1

Baicker Katherine · CIK 0001537067 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,118.407

SEC source: 0000059478-24-000264 · wk-form4_1732137757.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,540.938

F1 · shares: Includes 18 shares received in distributions in August 2024.

SEC source: 0000059478-24-000266 · wk-form4_1732137825.xml · nonDerivative · entry 2

Hedley Mary Lynne · CIK 0001340823 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,864.122

SEC source: 0000059478-24-000266 · wk-form4_1732137825.xml · nonDerivative · entry 1

Hedley Mary Lynne · CIK 0001340823 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,561.592

F1 · shares: At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-24-000268 · wk-form4_1732137888.xml · nonDerivative · entry 1

JACKSON JAMERE · CIK 0001601813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,153.593

SEC source: 0000059478-24-000270 · wk-form4_1732137954.xml · nonDerivative · entry 2

JOHNSON KIMBERLY H · CIK 0001658089 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,015.348

SEC source: 0000059478-24-000270 · wk-form4_1732137954.xml · nonDerivative · entry 1

JOHNSON KIMBERLY H · CIK 0001658089 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,712.818

F1 · shares: At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-24-000272 · wk-form4_1732138010.xml · nonDerivative · entry 1

Kaelin William G Jr · CIK 0001551715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,464.71

SEC source: 0000059478-24-000274 · wk-form4_1732138066.xml · nonDerivative · entry 2

LUCIANO JUAN R · CIK 0001455792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,146.533

SEC source: 0000059478-24-000274 · wk-form4_1732138066.xml · nonDerivative · entry 1

LUCIANO JUAN R · CIK 0001455792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,844.003

F1 · shares: At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-24-000276 · wk-form4_1732138122.xml · nonDerivative · entry 2

Sulzberger Gabrielle · CIK 0001262388 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,516.624

SEC source: 0000059478-24-000276 · wk-form4_1732138122.xml · nonDerivative · entry 1

Sulzberger Gabrielle · CIK 0001262388 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,214.094

F1 · shares: At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-24-000278 · wk-form4_1732138184.xml · nonDerivative · entry 1

Walker Karen · CIK 0001642519 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,248.823

SEC source: 0000059478-24-000255 · wk-form4_1731100686.xml · nonDerivative · entry 1

Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,480

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023.

SEC source: 0000059478-24-000249 · wk-form4_1730841188.xml · derivative · entry 4

Dozier Eric · CIK 0001955972 · EVP, HR & Diversity

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,534 shares

Expires 2024-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

SEC source: 0000059478-24-000249 · wk-form4_1730841188.xml · nonDerivative · entry 2

Dozier Eric · CIK 0001955972 · EVP, HR & Diversity

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,042.597

SEC source: 0000059478-24-000249 · wk-form4_1730841188.xml · nonDerivative · entry 1

Dozier Eric · CIK 0001955972 · EVP, HR & Diversity

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,724

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000059478-24-000251 · wk-form4_1730841247.xml · derivative · entry 4

Hernandez Edgardo · CIK 0001861052 · EVP & Pres., Mfg. Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,687 shares

Expires 2024-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.